A comment on congenital prothrombin abnormalities associated with thrombosis but not with bleeding

[1]  D. Grobbee,et al.  The Utility of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African Cohort , 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  Y. Kanai,et al.  A paradoxical thrombogenic mutation in factor II at the target site of arthropod bleeding toxin. , 2019, European journal of medical genetics.

[3]  S. Ferrari,et al.  The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance , 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[4]  A. Takagi,et al.  Familial pulmonary thromboembolism with a prothrombin mutation and antithrombin resistance. , 2018, Journal of cardiology cases.

[5]  S. Ferrari,et al.  Bleeding manifestations in heterozygotes with prothrombin deficiency or abnormalities vs. unaffected family members as observed during a long follow-up study , 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[6]  D. Radojkovic,et al.  Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism , 2017, Journal of thrombosis and haemostasis : JTH.

[7]  P. Simioni,et al.  New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[8]  H. Kiyoi,et al.  The first case of antithrombin-resistant prothrombin Belgrade mutation in Japanese , 2016, Annals of Hematology.

[9]  D. Radojkovic,et al.  A novel prothrombin mutation in two families with prominent thrombophilia – the first cases of antithrombin resistance in a Caucasian population , 2013, Journal of thrombosis and haemostasis : JTH.

[10]  R. De Cristofaro,et al.  Congenital Prothrombin Deficiency: An Update , 2013, Seminars in Thrombosis & Hemostasis.

[11]  S. Nair,et al.  Molecular defect of 'Prothrombin Amrita': substitution of arginine by glutamine (Arg553 to Gln) near the Na(+) binding loop of prothrombin. , 2013, Blood cells, molecules & diseases.

[12]  T. Naoe,et al.  Thrombosis from a prothrombin mutation conveying antithrombin resistance. , 2012, The New England journal of medicine.

[13]  A. Bertomoro,et al.  Congenital deficiencies and abnormalities of prothrombin. , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[14]  A. O'marcaigh,et al.  Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia. , 1996, Blood.

[15]  S. J. Degen,et al.  Prothrombin Frankfurt: A Dysfunctional Prothrombin Characterized by Substitution of Glu-466 by Ala , 1995, Thrombosis and Haemostasis.

[16]  H. Asakura,et al.  Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His). , 1992, Blood.

[17]  S. Iwanaga,et al.  Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity. , 1992, Biochemistry.

[18]  A. Quick.  CONGENITAL HYPOPROTHROMBINÆMIA AND PSEUDO-HYPOPROTHROMBINÆMIA , 1947 .

[19]  A. Quick.  Congenital hypoprothrombinaemia and pseudo-hypoprothrombinaemia. , 1947, Lancet.